Drugs.com: Escitalopram reduces symptoms of anxiety in teens

Outlet covers UC research that points to a possible new treatment for adolescent anxiety

For adolescents with generalized anxiety disorder, UC research has shown that the medication escitalopram could reduce symptoms. The study was published online Aug. 25 in The Journal of Clinical Psychiatry.

Jeffrey Strawn, MD, associate professor and anxiety expert in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati, and colleagues treated adolescents with anxiety disorder with escitalopram or a placebo for eight weeks to see if improvement occurred.

"For clinicians treating anxious adolescents, this study provides preliminary answers to important questions about the effectiveness of this treatment," Strawn says.

Read the full Drugs.com story.

Psych Central also reported on this research.

Read the full UC News release.

Featured photo courtesy of Unsplash.

Next Lives Here

The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.

Related Stories

2

How are tariffs impacting your retirement plans?

May 15, 2025

WVXU sat down with University of Cincinnati’s Michael Neugent for a look into how tariffs impact the markets, retirement funds and inflation. Neugent, associate professor-educator at Lindner College of Business and Director of the MS Finance Program, said that investors in the stock market prefer certainty in fiscal policy to help them map out investment decisions. “Right now, that lack of certainty is providing some angst within the market and investors,” he told WVXU. Many U.S. companies will face challenges from tariffs, but pauses on tariff plans can sometimes lead to more questions than answers.

Debug Query for this